Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Variables Associated With a Significant (≥20%) LS Decrease in SVR Variable (n = 175) | Significant LS Decrease (n = 101) | No Significant LS Decrease (n = 74) | P Value | Adjusted Odds Ratio (95% CI) | P Value: Vitamin D, ng/mL | 61.6 (49.3 to 72.5) | 61.8 (47.2 to 73.4) | .981 | |
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
All participants were evaluated using a common protocol.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Influence of Cellular Aging on Liver Stiffness in Patients With Hepatitis C Virus Achieving Sustained Viral Response
Study design awaiting verification · The Journal of Infectious Diseases · 2025
Original publication title
Influence of Cellular Aging on Liver Stiffness in Patients With Hepatitis C Virus Achieving Sustained Viral Response
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Liver stiffness (LS) is not reduced in 10%: 30% of patients who achieve sustained viral response (SVR) after hepatitis C virus (HCV) elimination with direct-acting antivirals (DAA). Our aim was to analyze whether the parameters associated with cellular aging measured at the DAA initiation date are related to LS reduction upon achieving SVR.
Source: BackgroundAbstract: What methods does the paper describe?
In a prospective cohort study (GEHEP-011) we measured several parameters associated with cellular aging, such as telomere attrition, mitochondrial alterations, and soluble biomarkers associated with senescence-associated secretory phenotype at the DAA initiation date, and examined their associations with a significant (≥20%) LS decrease at the SVR time point.
Source: MethodsAbstract: Clinical Trials Registration
NCT04460157.
Source: Clinical Trials RegistrationAbstract: Results
In total, 175 individuals were included in this study. In 101 (57.7%) patients, the LS reduction was ≥20% at SVR. In the multivariate analysis adjusted for sex, age, CXCL10, hsPCR, and CCL11 levels, greater relative telomere length (RTL) emerged as the sole variable independently associated with a significant LS decrease in SVR (1.102; 95% confidence interval, 1.001 to 1.1214; P = .047). Furthermore, changes in LS, including significant decrease, decrease <20%, or increase, were congruently associated with RTL (P = .011).
Source: ResultsAbstract: Conclusions
Greater RTL was independently associated with a significant LS reduction in SVR. Thus, increased cellular aging may be responsible for the absence of liver regeneration after HCV eradication. Further studies are required to assess the long-term effects of cellular aging after SVR.
Source: ConclusionsAuthors’ abstract
Abstract
Background
Liver stiffness (LS) is not reduced in 10%: 30% of patients who achieve sustained viral response (SVR) after hepatitis C virus (HCV) elimination with direct-acting antivirals (DAA). Our aim was to analyze whether the parameters associated with cellular aging measured at the DAA initiation date are related to LS reduction upon achieving SVR.
Methods
In a prospective cohort study (GEHEP-011) we measured several parameters associated with cellular aging, such as telomere attrition, mitochondrial alterations, and soluble biomarkers associated with senescence-associated secretory phenotype at the DAA initiation date, and examined their associations with a significant (≥20%) LS decrease at the SVR time point.
Results
In total, 175 individuals were included in this study. In 101 (57.7%) patients, the LS reduction was ≥20% at SVR. In the multivariate analysis adjusted for sex, age, CXCL10, hsPCR, and CCL11 levels, greater relative telomere length (RTL) emerged as the sole variable independently associated with a significant LS decrease in SVR (1.102; 95% confidence interval, 1.001 to 1.1214; P = .047). Furthermore, changes in LS, including significant decrease, decrease <20%, or increase, were congruently associated with RTL (P = .011).
Conclusions
Greater RTL was independently associated with a significant LS reduction in SVR. Thus, increased cellular aging may be responsible for the absence of liver regeneration after HCV eradication. Further studies are required to assess the long-term effects of cellular aging after SVR.
Clinical Trials Registration
NCT04460157.
Liver stiffness is not reduced in 10%: 30% of patients who achieve sustained viral response (SVR) after HCV elimination. Here, we report that greater relative telomere size is independently associated with a significant liver stiffness reduction in SVR.
Publication and source details
Original title: Influence of Cellular Aging on Liver Stiffness in Patients With Hepatitis C Virus Achieving Sustained Viral Response
Alejandro Gonzalez-Serna; Anaïs Corma-Gomez; Mercedes Cano; Ricardo Rubio-Sánchez; Carmen Martín-Sierra; Pilar Rincón; Jesica Martín-Carmona; Margarita Pérez; Juan Antonio Pineda; Luis Miguel Real; Juan Macias
The Journal of Infectious Diseases · 2025
L. M. R. and J. M. contributed equally.
Potential conflicts of interest. J. M. has been an investigator in clinical trials supported by Bristol-Myers Squibb, Gilead, and Merck Sharp & Dome; and has received lecture fees from Gilead, Bristol-Myers Squibb, Merck Sharp & Dome, and consulting fees from Bristol Myers Squibb, Gilead, and Merck Sharp & Dome. J. A. P. has received consulting fees from Bristol-Myers Squibb, AbbVie, ViiV Healthcare, Gilead, MSD, and Janssen Cilag. A. C. G. has received fees for lectures from Gilead. All other authors report no potential conflicts.
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T04:53:43.199074+00:00
DOI: 10.1093/infdis/jiaf087 · PMC12128080